Mutagenesis and Genome Engineering of Epstein-Barr Virus in Cultured Human Cells by CRISPR/Cas9
- PMID: 27709566
- DOI: 10.1007/978-1-4939-6472-7_2
Mutagenesis and Genome Engineering of Epstein-Barr Virus in Cultured Human Cells by CRISPR/Cas9
Abstract
The clustered regularly interspaced short palindromic repeats (CRISPR)-CRISPR associated protein 9 nuclease (Cas9) system is a powerful genome-editing tool for both chromosomal and extrachromosomal DNA. DNA viruses such as Epstein-Barr virus (EBV), which undergoes episomal replication in human cells, can be effectively edited by CRISPR/Cas9. We have demonstrated targeted editing of the EBV genome by CRISPR/Cas9 in several lines of EBV-infected cells. CRISPR/Cas9-based mutagenesis and genome engineering of EBV provides a new method for genetic analysis, which has some advantages over bacterial artificial chromosome-based recombineering. This approach might also prove useful in the cure of EBV infection. In this chapter, we use the knockout of the BART promoter as an example to detail the experimental procedures for construction of recombinant EBV in human cells.
Keywords: Cure of Epstein–Barr virus infection; Episomal viral DNA genome; Epstein–Barr virus; Genetic analysis of Epstein–Barr virus; RNA-guided genome editing.
Similar articles
-
CRISPR/Cas9-mediated genome editing of Epstein-Barr virus in human cells.J Gen Virol. 2015 Mar;96(Pt 3):626-636. doi: 10.1099/jgv.0.000012. Epub 2014 Dec 12. J Gen Virol. 2015. PMID: 25502645
-
Use of CRISPR/Cas Genome Editing Technology for Targeted Mutagenesis in Rice.Methods Mol Biol. 2017;1498:33-40. doi: 10.1007/978-1-4939-6472-7_3. Methods Mol Biol. 2017. PMID: 27709567
-
Highly Efficient CRISPR/Cas9-Mediated Cloning and Functional Characterization of Gastric Cancer-Derived Epstein-Barr Virus Strains.J Virol. 2016 Apr 14;90(9):4383-93. doi: 10.1128/JVI.00060-16. Print 2016 May. J Virol. 2016. PMID: 26889033 Free PMC article.
-
Rapid CRISPR/Cas9-Mediated Cloning of Full-Length Epstein-Barr Virus Genomes from Latently Infected Cells.Viruses. 2018 Apr 3;10(4):171. doi: 10.3390/v10040171. Viruses. 2018. PMID: 29614006 Free PMC article. Review.
-
[The application of CRISPR-Cas9 gene editing technology in viral infection diseases].Yi Chuan. 2015 May;37(5):412-8. doi: 10.16288/j.yczz.14-460. Yi Chuan. 2015. PMID: 25998428 Review. Chinese.
Cited by
-
Latest Advances of Virology Research Using CRISPR/Cas9-Based Gene-Editing Technology and Its Application to Vaccine Development.Viruses. 2021 Apr 28;13(5):779. doi: 10.3390/v13050779. Viruses. 2021. PMID: 33924851 Free PMC article. Review.
-
Genome editing of pseudorabies virus in the CRISPR/Cas9 era: a mini-review.Front Vet Sci. 2023 Jul 5;10:1237186. doi: 10.3389/fvets.2023.1237186. eCollection 2023. Front Vet Sci. 2023. PMID: 37476821 Free PMC article. Review.
-
Class 2 CRISPR/Cas: an expanding biotechnology toolbox for and beyond genome editing.Cell Biosci. 2018 Nov 12;8:59. doi: 10.1186/s13578-018-0255-x. eCollection 2018. Cell Biosci. 2018. PMID: 30459943 Free PMC article. Review.
-
Application of CRISPR/Cas9 Technology in Cancer Treatment: A Future Direction.Curr Oncol. 2023 Feb 6;30(2):1954-1976. doi: 10.3390/curroncol30020152. Curr Oncol. 2023. PMID: 36826113 Free PMC article. Review.
-
A Broad Application of CRISPR Cas9 in Infectious Diseases of Central Nervous System.J Neuroimmune Pharmacol. 2019 Dec;14(4):578-594. doi: 10.1007/s11481-019-09878-7. Epub 2019 Sep 11. J Neuroimmune Pharmacol. 2019. PMID: 31512166 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
